Five PNNL technologies were recently awarded six R&D 100 honors. The R&D 100 Awards, now in its 58th year, recognize pioneers in science and technology from industry, the federal government, and academia.

The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.

PNNL lighting experts partnered with the city of Chicago to help identify the best street lighting technology and field validation approaches to Chicago’s outdoor lighting modernization effort.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

A technology that can quickly detect explosive vapors, deadly chemicals and illicit drugs with unparalleled accuracy has been named the 2020 Innovation of the Year by GeekWire, the Seattle-based technology news company.

Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.

The PNNL chemist is leading a joint effort to study circadian rhythms and the gut microbiome.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

Joint appointments at UW and OSU help PNNL’s Katrina Waters further collaborations in infectious disease and toxicology research.

To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.

PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

PNNL study evaluated "tunable" lighting and its effects on sleep at study in a California nursing home. Tunable refers to the ability to adjust LED light output and the warmth or coolness of the light color.

A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.